Forecast Insight - Migraine - Generic incursion inhibits market growth - http://www.companiesandmarkets.com adds new report

2009-01-09 11:29:01 - Forecast Insight - Migraine - Generic incursion inhibits market growth - a new market research report on www.companiesandmarkets.com

www.companiesandmarkets.com/Summary-Market-Report/Forecast-Insig ..

Introduction

Led by the seven triptan brands and Topamax´s (topiramate; Johnson & Johnson) continued uptake, seven major market migraine revenues grew strongly at an annual rate of 12.6% to total $4.1 billion in 2007.

Scope

*This report gives a strategic analysis of the likely impact that recent events will have on the future migraine market

*Includes migraine-specific sales forecasts for the key brands, generics, and pipeline agents in the seven major markets to 2017

*Provides a global market snapshot by including migraine-specific sales analysis for leading brands outside the seven major markets

*Key conclusions are supported by key opinion leader comment

Highlights

A 3-month direct-to-consumer (DTC) advertisement review process delayed print and televised branded marketing campaigns for Treximet until late September 2008. As a result, early awareness of Treximet was crucially limited and so Datamonitor has marginally downgraded its forecast.

With continued key opinion leaders enthusiasm and promising Phase III comparator trial results, demonstrating a similar efficacy profile to AstraZeneca´s Zomig (zolmitriptan 5mg) and a potentially improved side-effect profile, Datamonitor has upgraded its migraine-specific sales forecast for Merck & Co´s telcagepant.

Datamonitor has considerably upgraded its migraine-specific sales forecast of Botox (botulinum toxin Type-A, Allergan). This is due to a greater than previously expected dosing regimen and Ipsen no longer assumed to be seeking a migraine label for its botulinum toxin brand Dysport, reducing future market competition.

Reasons to Purchase

*Understand when late-stage pipeline products will launch and what impact these will have on the market during the forecast period 2008 to 2017

*Quantify the current size of the seven major markets and the trends in the rest of the world

*Assess the impact of events, such as patent expiries and new product launches, on the migraine-specific sales of key brand name products